Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Aug;36(3):279-284.
doi: 10.1055/s-0039-1694066. Epub 2019 Aug 19.

Hepatocellular Carcinoma: Combined Transarterial Chemoembolization and Ablation

Josi L Herren  1 , Nerina Disomma  1 , Charles E Ray Jr  1
Affiliations
Review

Hepatocellular Carcinoma: Combined Transarterial Chemoembolization and Ablation

Josi L Herren et al. Semin Intervent Radiol. 2019 Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest None.

Figures

Fig. 1
Fig. 1
A 48-year-old male with past medical history of hepatis C and alcoholic liver cirrhosis with intermediate segment 7 hepatocellular carcinoma in 2014. Patient was treated with transarterial chemoembolization/radiofrequency ablation (TACE/RFA) in December 2014, which was a bridge till the patient received transplant in August 2017. (Case courtesy of Ron Gaba, MD.) Triple phase CT demonstrating intermediate hepatocellular carcinoma. ( a ) Arterial phase hyperenhancement of lesion within segment 7 of the liver, measuring 3.4 cm (arrow). ( b ) Rapid portal venous washout. ( c ) RFA to segment 7 lesion under ultrasound guidance (arrow). ( d ) TACE infusion to segment 7 lesion (arrows). ( e, f ) Demonstration of posttreatment changed with dense lipiodol core and surrounding hypodense rim from RFA.
See this image and copyright information in PMC

References

    1. U.S. Cancer Statistics Working Group. Available at:www.cdc.gov/cancer/USCS/about/index. Accessed July 26, 2019
    1. American Cancer Society. Available at:https://cancerstatisticscenter.cancer.org. Accessed July 19, 2019
    1. Vogl T J, Naguib N N, Nour-Eldin N E et al.Transarterial chemoembolization in the treatment of patients with unresectable cholangiocarcinoma: results and prognostic factors governing treatment success. Int J Cancer. 2012;131(03):733–740. - PubMed
    1. Dong X D, Carr B I. Hepatic artery chemoembolization for the treatment of liver metastases from neuroendocrine tumors: a long-term follow-up in 123 patients. Med Oncol. 2011;28 01:S286–S290. - PubMed
    1. Martin R C, Joshi J, Robbins K et al.Hepatic intra-arterial injection of drug-eluting bead, irinotecan (DEBIRI) in unresectable colorectal liver metastases refractory to systemic chemotherapy: results of multi-institutional study. Ann Surg Oncol. 2011;18(01):192–198. - PubMed